Method Medical Media launches
London-based agency begins trading today - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/method_medical_media_launches_1204334London-based agency begins trading today - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/method_medical_media_launches_1204334Appointment boosts healthcare offering - Appointments - PharmaTimes
by George Underwood
www.pharmatimes.com/appointments/lansons_recruits_kate_aldous_1029021We asked the winning companies from the 2017 Communications Team of the Year competition what pharma’s comms priorities should be - Magazine Article - PharmaTimes
by George Underwood
www.pharmatimes.com/magazine/2018/janfeb/loud_and_clearTrial was evaluating the drug in patients with embolic stroke of undetermined source (ESUS). - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/bayer_halts_xarelto_trial_1207036- Appointments - PharmaTimes
by George Underwood
www.pharmatimes.com/appointments/new_general_manager_for_abbie_uk_1195687Five years on from Pfizer selling Discovery Park, the site’s current chief executive Toby Hunter tells PharmaTimes about the plans for its future - Magazine Article - PharmaTimes
by George Underwood
www.pharmatimes.com/magazine/2017/november_2017/age_of_discoveryCompany will focus on existing HCV drug ZEPATIER - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/merck_discontinues_hcv_programmes_1206606New hires from Bisector 2 and Tonic - Appointments - PharmaTimes
by George Underwood
www.pharmatimes.com/appointments/90ten_boosts_pr_division_1022156How this Oxford spinout is using AI to tackle challenges in non-alcoholic fatty liver disease - Magazine Article - PharmaTimes
by George Underwood
www.pharmatimes.com/magazine/2018/april_2018/company_focus_perspectum_diagnosticsHumira is now the only EU biologic treatment option for children with the disease - News - PharmaTimes
by George Underwood
www.pharmatimes.com/news/humira_gets_ec_approval_for_anterior_uveitis_1205082